83-3899-69　Biotinylated Anti-Bevacizumab Antibody （AY13） （recommended for PK/PD） 200ug　BEB-BY13-200ug

特徴

• 背景
• A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor （VEGF）.
• Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF.
• Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.

仕様

• 容量：200ug
• Source：Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F（ab'）2.
• Species Reactivity：Mouse
• Host：Hybridoma
• Tag：-
• Molecule：Bevacizumab
• Format：Powder
• Conjugate：Biotin-labeled
• Purity：95％
• Buffer：PBS, pH7.4
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]